-
Mashup Score: 0FDA Approves Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia - 7 hour(s) ago
The FDA has approved obecabtagene autoleucel for relapsed/ refractory B-cell precursor acute lymphoblastic leukemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2
A phase 1b trial showed promising results among patients with relapsed or refractory chronic lymphocytic leukemia.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Patients with relapsed or refractory chronic lymphocytic #Leukemia saw benefits from treatment with fixed-duration Jaypirca plus Venclexta and Jaypirca plus Venclexta and Rituxan, according to a study. https://t.co/APfUtQ7omi
-
-
Mashup Score: 1FDA Approves First Menin Inhibitor for Relapsed, Refractory Acute Leukemia With KMT2A Translocation | Blood Cancers Today - 5 day(s) ago
The approval is based on results of the phase I/II AUGMENT-101 trial, where revumenib achieved a CR+CRh rate of 21%.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
🎉 The FDA has approved the first menin inhibitor, revumenib, for relapsed/refractory acute #leukemia with KMT2A translocation. 🗨️ "FDA approval of the first menin inhibitor is a major breakthrough," said @GhayasIssa in a press release from @Syndax. 📚 https://t.co/8MqJhHMGr4 https://t.co/22TQQIgLzH
-
-
Mashup Score: 0FDA Approves Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia - 6 day(s) ago
The FDA has approved obecabtagene autoleucel for relapsed/ refractory B-cell precursor acute lymphoblastic leukemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
BREAKING: @US_FDA Approves Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia #leukemia. https://t.co/HQNVMvxNeN https://t.co/OFpTZ8LQOR
-
-
Mashup Score: 1Cancer Helped Me See the Life I Prayed For - 7 day(s) ago
When eating, walking and bathing became difficult after cancer, my daughter stepped in. I was proud of who she had become.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Her whole life, Pam was afraid that her children did not know how much she loved them, and pondered if her children loved her enough, too. However, once she was diagnosed with acute myeloid #leukemia, the answers to those questions became clear. https://t.co/mKJfqLU6tc https://t.co/E3ZhHAjJZw
-
-
Mashup Score: 0FDA Approves Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia - 16 day(s) ago
The FDA has approved obecabtagene autoleucel for relapsed/ refractory B-cell precursor acute lymphoblastic leukemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
BREAKING: @US_FDA Approves Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia #leukemia. https://t.co/HQNVMvxNeN https://t.co/OFpTZ8LQOR
-
-
Mashup Score: 4The Pathway of Cancer is Fraught with Anxiety - 17 day(s) ago
As a patient with chronic lymphocytic leukemia, I recently gleaned three new insights from my oncologist and phlebotomist.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
While recovering from chemotherapy for chronic lymphocytic #leukemia, Chester tries his best to live his life normally, although there are still some feelings of anxiety and uncertainty. Read more here: https://t.co/MNj74EMBFu https://t.co/NeuHwzVjD2
-
-
Mashup Score: 0Methotrexate’s Approval Expanded to Include Pediatric ALL - 24 day(s) ago
The FDA expanded the approval of methotrexate to include patients with pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis.
Source: www.oncnursingnews.comCategories: General Medicine News, Oncologists1Tweet-
The FDA approval of methotrexate (Jylamvo) has been expanded to include pediatric patients with acute lymphoblastic #leukemia. https://t.co/m5SoHiVV1W
-
-
Mashup Score: 0
Treatment with Scemblix was shown to improve response rates in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
The @US_FDA granted accelerated approval to Scemblix for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid #leukemia in chronic phase. https://t.co/otF4eWrGjV
-
-
Mashup Score: 0Chemo vs HMAs and Venclexta Show Similar Survival Outcomes in AML - 1 month(s) ago
Adjusted survival outcomes were similar for patients with NPM1-mutated AML with intensive induction chemotherapy or hypomethylating agents and Venclexta.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
For patients with NPM1-mutant acute myeloid #leukemia, adjusted survival outcomes were similar following intensive induction chemotherapy and the combination of hypomethylating agents and Venclexta, as per a study. https://t.co/sNLcpVt5Vb
-
BREAKING: @US_FDA Approves Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia #leukemia. https://t.co/HQNVMvxNeN https://t.co/OFpTZ8LQOR